• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根据甲状腺眼病活动水平,利用光学相干断层扫描测量黄斑中心凹下脉络膜厚度的观察性研究比较——系统评价与荟萃分析

A Comparison of Observational Studies on Subfoveal Choroidal Thickness Measured with OCT according to the Level of Thyroid Eye Disease Activity-Systematic Review and Meta-Analysis.

作者信息

Kowalik-Jagodzińska Małgorzata, Sobol Maria, Turno-Kręcicka Anna

机构信息

Department of Ophthalmology, Wroclaw Medical University, 50-367 Wrocław, Poland.

Department of Biophysics Physiology and Pathophysiology, Medical University of Warsaw, 02-004 Warszawa, Poland.

出版信息

J Clin Med. 2023 Jul 17;12(14):4720. doi: 10.3390/jcm12144720.

DOI:10.3390/jcm12144720
PMID:37510836
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10380986/
Abstract

This study aims to systematise subfoveal choroidal thickness (SFCT) measured using optical coherence tomography (OCT) in patients with different severities of thyroid eye disease (TED) compared with healthy subjects. The PubMed, Web of Science and Scopus databases were searched for the following terms: ((Graves' ophthalmopathy) OR (thyroid eye disease) OR (Graves' orbitopathy) OR (thyroid-associated orbitopathy)) AND (choroidal thickness) AND ((optical coherence tomography) OR (OCT)). The pool of papers was narrowed down to articles published until 31 January 2023 (26, 26 and 96 papers, respectively). Twenty-five (25) articles were taken into consideration, which were original papers and included the choroidal thickness measurements among TED patients in their results. Finally, eight papers were included in the comparative analysis of the SFCT parameter in TED patients and a group of healthy controls, and seven papers in the comparative analysis of the same parameter between active and inactive TED patients. The mean value of the difference between the TED group and the healthy group was 38.79 μm, with a confidence interval (CI) from 0.09 to 77.49 μm ( = 0.0495). The mean difference between the active TED group and inactive TED group was 38.02 μm, with a CI from 8.62 to 67.42 μm ( = 0.0113). All the results were statistically significant.

摘要

本研究旨在对甲状腺眼病(TED)不同严重程度患者使用光学相干断层扫描(OCT)测量的黄斑中心凹下脉络膜厚度(SFCT)进行系统化,并与健康受试者进行比较。在PubMed、Web of Science和Scopus数据库中搜索了以下术语:((格雷夫斯眼病)或(甲状腺眼病)或(格雷夫斯眶病)或(甲状腺相关眶病))与(脉络膜厚度)以及((光学相干断层扫描)或(OCT))。论文库被缩小到截至2023年1月31日发表的文章(分别为26篇、26篇和96篇)。考虑了25篇文章,这些文章均为原创论文,其结果中包括了TED患者的脉络膜厚度测量。最后,8篇论文纳入了TED患者与健康对照组SFCT参数的比较分析,7篇论文纳入了活动期与非活动期TED患者同一参数的比较分析。TED组与健康组之间差异的平均值为38.79μm,置信区间(CI)为0.09至77.49μm(P = 0.0495)。活动期TED组与非活动期TED组之间的平均差异为38.02μm,CI为8.62至67.42μm(P = 0.0113)。所有结果均具有统计学意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54b9/10380986/fbac67d87f12/jcm-12-04720-g007a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54b9/10380986/6633828fe47d/jcm-12-04720-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54b9/10380986/789af844fd00/jcm-12-04720-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54b9/10380986/44b933b2d2d9/jcm-12-04720-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54b9/10380986/70f55b1c9d21/jcm-12-04720-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54b9/10380986/2c62a0636e9d/jcm-12-04720-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54b9/10380986/98206d35889d/jcm-12-04720-g006a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54b9/10380986/fbac67d87f12/jcm-12-04720-g007a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54b9/10380986/6633828fe47d/jcm-12-04720-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54b9/10380986/789af844fd00/jcm-12-04720-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54b9/10380986/44b933b2d2d9/jcm-12-04720-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54b9/10380986/70f55b1c9d21/jcm-12-04720-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54b9/10380986/2c62a0636e9d/jcm-12-04720-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54b9/10380986/98206d35889d/jcm-12-04720-g006a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54b9/10380986/fbac67d87f12/jcm-12-04720-g007a.jpg

相似文献

1
A Comparison of Observational Studies on Subfoveal Choroidal Thickness Measured with OCT according to the Level of Thyroid Eye Disease Activity-Systematic Review and Meta-Analysis.根据甲状腺眼病活动水平,利用光学相干断层扫描测量黄斑中心凹下脉络膜厚度的观察性研究比较——系统评价与荟萃分析
J Clin Med. 2023 Jul 17;12(14):4720. doi: 10.3390/jcm12144720.
2
Changes in choroidal thickness and choroidal vascularity index in thyroid eye disease: a systematic review.甲状腺眼病中脉络膜厚度和脉络膜血管指数的变化:系统评价。
Orbit. 2024 Jun;43(3):399-407. doi: 10.1080/01676830.2022.2146726. Epub 2022 Nov 27.
3
Choroidal thickness in thyroid eye disease and its correlation with disease activity.甲状腺眼病中的脉络膜厚度及其与疾病活动度的相关性。
Indian J Ophthalmol. 2024 Feb 1;72(2):281-286. doi: 10.4103/IJO.IJO_848_23. Epub 2023 Dec 26.
4
Evaluation of choroidal thickness and retinal vessel density in patients with inactive Graves' orbitopathy.静止期Graves眼病患者脉络膜厚度及视网膜血管密度的评估
Photodiagnosis Photodyn Ther. 2020 Dec;32:101898. doi: 10.1016/j.pdpdt.2020.101898. Epub 2020 Jun 24.
5
Evaluation of Retinal Neurodegeneration and Choroidal Thickness in Patients with Inactive Graves' Ophthalmopathy.评估不活动期格雷夫斯眼病患者的视网膜神经退行性变和脉络膜厚度。
Klin Monbl Augenheilkd. 2021 Jul;238(7):797-802. doi: 10.1055/a-1275-0703. Epub 2021 Mar 17.
6
Evaluation of the Effect of Proptosis on Choroidal Thickness in Graves' Ophthalmopathy.Graves 眼病突眼对脉络膜厚度影响的评估。
Turk J Ophthalmol. 2020 Aug 26;50(4):221-227. doi: 10.4274/tjo.galenos.2020.97415.
7
Assessment of choroidal perfusion indices in thyroid eye disease by using optical coherence tomography.采用光学相干断层扫描评估甲状腺眼病的脉络膜灌注指数。
Indian J Ophthalmol. 2024 Nov 1;72(11):1639-1644. doi: 10.4103/IJO.IJO_3315_23. Epub 2024 May 20.
8
Choroidal Thickness in Thyroid Eye Disease: Comparison With Controls and Application in Diagnosing Non-Inflammatory Active Disease.甲状腺眼病中的脉络膜厚度:与对照组比较及在诊断非炎性活动性疾病中的应用
Cureus. 2021 Nov 20;13(11):e19779. doi: 10.7759/cureus.19779. eCollection 2021 Nov.
9
Choroidal structural evaluation in inactive Graves' ophthalmopathy.静止期 Graves 眼病的脉络膜结构评估。
Photodiagnosis Photodyn Ther. 2022 Sep;39:103012. doi: 10.1016/j.pdpdt.2022.103012. Epub 2022 Jul 9.
10
Choroidal Thickness in Patients with Graves' Ophthalmopathy.格雷夫斯眼病患者的脉络膜厚度
Curr Eye Res. 2017 Mar;42(3):484-490. doi: 10.1080/02713683.2016.1198488. Epub 2016 Jul 15.

引用本文的文献

1
Clinical science effects of different mydriatics on retinal and choroidal parameters in healthy adults observed by widefield swept-source optical coherence tomography.通过广角扫频光学相干断层扫描观察不同散瞳剂对健康成年人视网膜和脉络膜参数的临床科学影响。
BMJ Open Ophthalmol. 2025 Jul 8;10(1):e001963. doi: 10.1136/bmjophth-2024-001963.
2
Retinal and Choroidal Alterations in Thyroid-Associated Ophthalmopathy: A Systematic Review.甲状腺相关性眼病的视网膜和脉络膜改变:一项系统评价
Life (Basel). 2025 Feb 13;15(2):293. doi: 10.3390/life15020293.
3
Optical coherence tomography angiography in thyroid associated ophthalmopathy: a systematic review.

本文引用的文献

1
Orbital and ocular perfusion in thyroid eye disease.甲状腺眼病的眼眶和眼血流。
Surv Ophthalmol. 2023 May-Jun;68(3):481-506. doi: 10.1016/j.survophthal.2023.01.003. Epub 2023 Jan 18.
2
Changes in choroidal thickness and choroidal vascularity index in thyroid eye disease: a systematic review.甲状腺眼病中脉络膜厚度和脉络膜血管指数的变化:系统评价。
Orbit. 2024 Jun;43(3):399-407. doi: 10.1080/01676830.2022.2146726. Epub 2022 Nov 27.
3
The Effects of chronic smoking on retinal vascular densities and choroidal thicknesses measured by optical coherence tomography angiography.
光学相干断层扫描血管造影在甲状腺相关眼病中的应用:系统评价。
BMC Ophthalmol. 2024 Jul 22;24(1):304. doi: 10.1186/s12886-024-03569-5.
慢性吸烟对通过光学相干断层扫描血管造影测量的视网膜血管密度和脉络膜厚度的影响。
Eur J Ophthalmol. 2023 Jan;33(1):455-462. doi: 10.1177/11206721221124650. Epub 2022 Sep 9.
4
Choroidal structural evaluation in inactive Graves' ophthalmopathy.静止期 Graves 眼病的脉络膜结构评估。
Photodiagnosis Photodyn Ther. 2022 Sep;39:103012. doi: 10.1016/j.pdpdt.2022.103012. Epub 2022 Jul 9.
5
Graves' Ophthalmopathy in the Setting of Primary Hypothyroidism.原发性甲状腺功能减退症背景下的格雷夫斯眼病
Cureus. 2022 May 12;14(5):e24954. doi: 10.7759/cureus.24954. eCollection 2022 May.
6
Pathophysiology of thyroid-associated orbitopathy.甲状腺相关性眼病的病理生理学。
Best Pract Res Clin Endocrinol Metab. 2023 Mar;37(2):101620. doi: 10.1016/j.beem.2022.101620. Epub 2022 Feb 5.
7
Choroidal vascularity index in thyroid eye disease: comparison with controls and application in diagnosing non-inflammatory active disease.甲状腺眼病的脉络膜血流指数:与对照组的比较及在诊断非炎症性活动疾病中的应用。
Orbit. 2022 Feb;41(1):89-96. doi: 10.1080/01676830.2021.2014893. Epub 2022 Jan 4.
8
Choroidal Thickness in Thyroid Eye Disease: Comparison With Controls and Application in Diagnosing Non-Inflammatory Active Disease.甲状腺眼病中的脉络膜厚度:与对照组比较及在诊断非炎性活动性疾病中的应用
Cureus. 2021 Nov 20;13(11):e19779. doi: 10.7759/cureus.19779. eCollection 2021 Nov.
9
2021 update on thyroid-associated ophthalmopathy.2021 年甲状腺相关眼病更新。
J Endocrinol Invest. 2022 Feb;45(2):235-259. doi: 10.1007/s40618-021-01663-9. Epub 2021 Aug 20.
10
Choroidal vascularity index in thyroid-associated ophthalmopathy.甲状腺相关眼病的脉络膜血流指数。
Can J Ophthalmol. 2023 Feb;58(1):27-33. doi: 10.1016/j.jcjo.2021.06.023. Epub 2021 Jul 26.